Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,482 INR | +0.10% |
|
-3.81% | +18.98% |
06-25 | US FDA Classifies Inspection of Cipla's Patalganga Manufacturing Facility as Voluntary Action Indicated | MT |
06-24 | INDIA STOCKS-Financials weigh on Indian shares; small-, mid-caps fall | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.98% | 14.33B | |
+21.46% | 43.59B | |
+28.36% | 22.54B | |
+21.43% | 15.73B | |
+55.79% | 12.75B | |
-0.05% | 6.79B | |
-12.58% | 6.48B | |
-8.87% | 5.73B | |
+15.72% | 5.67B | |
+8.29% | 4.67B |
- Stock Market
- Equities
- CIPLA Stock
- News Cipla Limited
- Cipla to Invest Additional 3 Million Euros in Germany's Ethris